VHL haploinsufficiency, or the reduction of VHL dose, as seen upon “first hit”, is not sufficient to fuel cancer, however, it shifts metabolism by activating some of the Warburg effect factors and some of the mediators of glutamine reductive metabolism, effectively placing the cells on the path to transformation [216]. Here, VHL is linked to cancer.